events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Alpha Therapy
,
Cancer Therapies
,
Cancer Treatment
,
Healthcare Technology
,
Lead-212
,
Nuclear Medicine
,
Oncology
,
Orano Med
,
Precision Oncology
,
Radioligand Therapies
,
Radioligand Therapy
,
Targeted Alpha Therapies
,
Targeted Alpha Therapy
October 5, 2026
Orano Med Opens ATLab Valenciennes, Europe’s First Industrial Facility for Lead-212 Targeted Alpha Therapies
Cancer Therapies
,
Companion Diagnostics
,
Guardant Health
,
Guardant Infinity Smart Platform
,
Liquid Biopsy
,
Merck
,
Precision Oncology
January 20, 2026
Guardant Health & Merck Develop Companion Diagnostics & Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
Load More
